TrialJNCI cancer spectrum2023

Radium-223 in metastatic castration-resistant prostate cancer: whole-body diffusion-weighted magnetic resonance imaging scanning to assess response.

Chris Parker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.